跳至主要内容
临床试验/NCT03998826
NCT03998826Unknown不适用

Effect of Piroxicam Premedication on Postendodontic Pain in Mandibular Molars With Non-vital Pulp: A Randomized Controlled Trial

Cairo University0 个研究点目标入组 60 人开始时间: 2019年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
60
主要终点
Postendodontic pain using a pain-measuring scale

研究概览

简要总结

The aim of the study is to evaluate the effect of piroxicam (20mg) compared to placebo on post-endodontic pain of single-visit endodontic treatment of non-vital mandibular molars.

详细描述

  • Patients will be clinically and radiographically examined and their eligibility will be assessed. Eligible patients will be treated in one visit.
  • Patients will be randomly assigned to one of 2 groups: experimental group (premedication with 20 mg of piroxicam) and the control group (premedication with placebo). Each participant will receive a standard inferior alveolar nerve block injection. After endodontic treatment, patients will be given postoperative instructions and informed, in case of pain, to receive ibuprofen 200 mg as rescue medication.
  • Postendodontic pain intensity and incidence at the different pain categories (No, mild, moderate, severe) will be assessed 6, 12, 24, 48, 72 hours and 7 days postoperatively using a 0-10 numerical rate scale (NRS). Analgesic intake throughout the 7 days will be recorded.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

The study will be participant and operator-blind where the participant and operator will not know the intervention done.

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aging between 18-50 years old
  • Patients with mandibular molar with non-vital pulp.
  • Systemically- healthy patients (ASA I or II).
  • Patients who agree to attend for recall appointments and provide a written consent.

排除标准

  • Pregnant or lactating female patients.
  • Patients allergic to piroxicam.
  • History of peptic ulceration.
  • Periapical abscess, fistula.
  • Non-restorable teeth.
  • Moderate or severe marginal periodontitis i.e. pocket probe>3mm.

研究组 & 干预措施

Piroxicam drug

Experimental

20 mg piroxicam

干预措施: Piroxicam (Drug)

Placebo

Placebo Comparator

placebo

干预措施: Placebo (Drug)

结局指标

主要结局

Postendodontic pain using a pain-measuring scale

时间窗: 7 days

Postoperative pain is measured using the Numerical Rating Scale (NRS) which is an 11-point scale from 0-10 where 0 represents no pain and 10 represents the worst pain measured 7 days after the first visit

次要结局

  • Analgesic medication intake incidence(7 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Asmaa Fathelrahman Mohamed

Postgraduate Student, Department of Endodontics, Faculty of Dentistry, Cairo University

Cairo University

相似试验